Grants for Independent school districts - Federal

This funding opportunity supports multi-site clinical trials for innovative treatments and interventions aimed at preventing or alleviating symptoms of Alzheimer's disease and related dementias, inviting applications from a diverse range of organizations and institutions.

This funding opportunity supports innovative research projects aimed at developing tools and treatments for diagnosing and mitigating injuries from radiation exposure during public health emergencies.

This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC will be considered not acceptable to this FOA.

This funding opportunity supports early-career clinical researchers in the U.S. to develop expertise in implementation science for substance use prevention and treatment through mentored clinical trials addressing the overdose crisis.

The "Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network" grant is a $3.8 million funding opportunity from the National Institutes of Health, specifically for Queen’s University at Kingston, to support its collaboration with the U.S. in conducting large-scale, multi-site clinical trials for innovative cancer treatments, while ensuring regulatory compliance and efficient data management.

The "Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD)" grant aims to fund the creation and testing of new, complex human cell models that accurately represent Alzheimer's and related dementias, with the goal of improving our understanding of these diseases and aiding in the development of potential therapies.

This grant provides funding for educational programs that improve the skills and knowledge of researchers analyzing large, complex datasets related to brain function, behavior, and social factors affecting health outcomes.

This funding opportunity supports established biomedical data repositories and knowledgebases to enhance their operations and community engagement, ensuring they remain vital resources for researchers in the biomedical field.

This funding opportunity provides financial support for a centralized coordination center that will ethically manage and enhance research on ancient human DNA, fostering collaboration among diverse scientific and community stakeholders.

This funding opportunity supports research that develops innovative tools to measure and enhance children's language development, particularly by engaging diverse communities and understanding environmental influences.

The purpose of this NOFO is to solicit applications for the Exploratory Advanced Research (EAR) Program to award cooperative agreements. The NOFO will result in the distribution of up to $2,000,000.The EAR program addresses the need for longer-term, higher risk breakthrough research with the potential for transformational improvements to plan, build, renew, and operate safe, congestion free, and environmentally sound transportation systems. The overall goal of this NOFO is to collect diverse pedestrian data, provide researchers access to this data, and encourage novel approaches for analysis of diverse data in support of increasing the safety and mobility of all people. The authority to enter into a cooperative agreement for this effort is found under 23 U.S.C. 502(b)(3)(C ). And funding for this effort is provided in in BIL (P. L. 117-58) Sec. 11101(c)(1)(A).

This program provides funding to state and local governments, schools, and nonprofits to implement strategies that enhance safety and prevent violence in K–12 schools.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

Grant Title: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) aims to fund innovative research to develop new treatments for genital herpes that can reduce viral shedding, prevent lesions, and lower transmission risks.

This funding opportunity supports early-stage research projects aimed at discovering new pain management targets within specific proteins, encouraging innovative approaches to develop non-addictive therapies for pain relief.

This funding opportunity supports research centers focused on developing innovative contraceptive methods, particularly non-hormonal options, and encourages participation from diverse institutions and underrepresented groups.

This funding opportunity supports innovative research and development of high-temperature geothermal energy technologies to unlock vast electricity production potential from deep rock formations across the United States.

This funding opportunity provides financial support and technical assistance to organizations working to establish and sustain residency programs in rural areas, helping to increase the number of physicians in underserved communities.

The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research that develops and tests new strategies for combining primary care, HIV, Hepatitis, and substance use disorder prevention and treatment services to improve health outcomes for individuals at high risk for or living with these conditions in the US.

This funding opportunity supports researchers in conducting early-stage clinical trials for innovative treatments and interventions targeting neurological disorders.